Closs sectional study for the usability of estimated hemoglobin A1c in type 2 diabetes with chronic kidney disease and hemodialysis.

Closs sectional study for the usability of estimated hemoglobin A1c in type 2 diabetes with chronic kidney disease and hemodialysis. - Study for the usability of estimated hemoglobin A1c in type 2 diabetes.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000011578

Enrollment

500

Registered

2013-08-27

Start date

2013-08-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes mellitus

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Outpatients of type 2 diabetes with chronic kidney disease and hemodialysis therapy.

Exclusion criteria

Exclusion criteria: Those who are less than 20 years old. Those who are suffer from severe disease other than type 2 diabetes and chronic kidney disease.

Design outcomes

Primary

Measure	Time frame
eHbA1c, plasma glucose, HbA1c, GA.	—

Secondary

Measure	Time frame
eGFR, BMI, hemoglobin, albumin, urinaly protein concentration and medications.	—

Countries

Japan

Contacts

Public ContactAkihiko Nakamura

Osafune clinic Internal medicine

osafune-clinic@nifty.com0869-26-8080

Outcome results